Welcome to our dedicated page for ALBEMARLE SEC filings (Ticker: ALB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Albemarle Corporation filings document operating results, material events, governance matters, shareholder voting items, and capital-structure disclosures for a public specialty chemicals and critical materials company. Form 8-K reports cover quarterly financial results, credit agreement amendments, debt-related actions, board appointments, officer transitions, and completed portfolio transactions.
Proxy materials describe director elections, committee governance, executive compensation, shareholder proposals, and voting procedures. Albemarle's filing record also documents the completed disposition of a controlling stake in Ketjen, retained ownership interests, integration of Performance Catalyst Solutions, and financing arrangements tied to the company's global lithium, bromine and specialty product businesses.
Albemarle Corporation reported that General Counsel & Secretary Ander C. Krupa had 188 shares of common stock withheld on February 24, 2026 at $186.83 per share to cover taxes on vested restricted stock units. After this tax-withholding disposition, Krupa directly owns 11,295 shares.
Albemarle Corp Chief People Officer Autumn M. Gagarinas reported automatic share disposals tied to tax withholding. On 2/24/2026, a total of 566 shares of common stock were withheld at $186.83 per share to cover tax liabilities from vesting restricted stock units granted on 2/24/2023. Following these tax-withholding dispositions, she directly held 3,488 shares of Albemarle common stock.
Albemarle Corporation senior vice president Cynthia Renee Lima reported automatic share disposals to cover taxes on restricted stock unit vesting. On the common stock, 196 shares and 144 shares were withheld on February 24, 2026 at a price of $186.83 per share as tax-withholding dispositions.
After these entries, she directly owned 12,559 common shares. A footnote explains that this filing also updates her reported holdings to include 4,806 unvested RSUs from awards granted on February 24, 2023, aligning treatment of time-based RSUs with other Albemarle reporting persons.
Albemarle Corp executive Melissa H. Anderson reported a tax-related share disposition. On 24 February 2026, 565 shares of common stock were withheld at $186.83 per share to cover tax liabilities tied to vesting restricted stock units granted on 24 February 2023. After this withholding, she directly held 8,874 shares. She also indirectly held 179.1617 shares through the Albemarle Corporation Retirement Savings Plan as of this Form 4.
Albemarle Corporation VP and CAO Donald J. LaBauve Jr. reported a tax-withholding disposition of 164 shares of Common Stock at $186.83 per share on Restricted Stock Units that vested from a grant dated 2/24/2023. After this, he directly holds 8,647 shares, and indirectly holds 12,755 shares through the Albemarle Savings Plan.
ALBEMARLE CORP Chief Commercial Officer Eric Norris reported a tax-related share disposition. On 2/24/2026, 887 shares of common stock were withheld at $186.83 per share to cover tax liabilities from vesting Restricted Stock Units granted on 2/24/2023. After this transaction, Norris directly holds 47,932 shares of Albemarle common stock.
Albemarle Corp Chief Supply Chain Officer Mark Richard Mummert reported a tax-related share disposition tied to restricted stock vesting. On 2/24/2026, 375 shares of common stock were withheld at $186.83 per share to cover tax liabilities, leaving him with 14,165 directly held shares.
Albemarle Corporation’s Chief Commercial Officer Eric Norris reported an open-market sale of company stock. On February 20, 2026, he sold 5,692 shares of Albemarle common stock at a price of $165.45 per share. After this transaction, he directly holds 48,819 shares of Albemarle common stock.
Albemarle Corporation director Gerald A. Steiner reported conversions of deferred phantom stock into common shares. On February 18, 2026, he exercised phantom stock units in two transactions, settling 153 units and 781 units into the same number of Albemarle common shares at a stated price of $0.00 per share.
The phantom stock represents deferred director compensation under Albemarle’s non‑employee director stock compensation and deferral plans, with units converting on a 1‑for‑1 basis into common stock and including dividend equivalent rights. Following these transactions, Steiner’s directly held common and phantom stock balances increased as part of his compensation arrangements rather than open‑market purchases.
ALB reports proposed insider sales of common stock by Eric W. Norris. The filing lists multiple planned dispositions dated 02/28/2023, 01/01/2024, 02/26/2024, and 02/28/2024. Examples shown include 1,112 shares on 02/28/2023 and 2,378 shares on 01/01/2024.